About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2013 (2013), Article ID 249080, 5 pages
http://dx.doi.org/10.1155/2013/249080
Research Article

The Accuracy of Prostate Cancer Localization Diagnosed on Transrectal Ultrasound-Guided Biopsy Compared to 3-Dimensional Transperineal Approach

Department of Surgery, Division of Urology, University of Colorado Denver School of Medicine, Academic Office One Building, Mail Stop C-319, 12631 East 17th Avenue, Room L15-5602, Aurora, CO 80045, USA

Received 26 October 2013; Revised 3 December 2013; Accepted 11 December 2013

Academic Editor: Fabio Campodonico

Copyright © 2013 Kevin Krughoff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. B. Barqawi, K. Krughoff, and K. Eid, “Current challenges in prostate cancer management and the rationale behind targeted focal therapy,” Advances in Urology, vol. 2012, Article ID 862639, 7 pages, 2012. View at Publisher · View at Google Scholar
  2. P. C. Albertsen, “Is screening for prostate cancer with prostate specific antigen an appropriate public health measure?” Acta Oncologica, vol. 44, no. 3, pp. 255–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. C. Albertsen, J. A. Hanley, and J. Fine, “20-Year outcomes following conservative management of clinically localized prostate cancer,” Journal of the American Medical Association, vol. 293, no. 17, pp. 2095–2101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Klotz, L. Zhang, A. Lam, R. Nam, A. Mamedov, and A. Loblaw, “Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer,” Journal of Clinical Oncology, vol. 28, no. 1, pp. 126–131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Lawrentschuk and L. Klotz, “Active surveillance for low-risk prostate cancer: an update,” Nature Reviews Urology, vol. 8, no. 6, pp. 312–320, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. R. Cooperberg, J. M. Broering, P. W. Kantoff, and P. R. Carroll, “Contemporary trends in low risk prostate cancer: risk assessment and treatment,” Journal of Urology, vol. 178, no. 3, pp. S14–S19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. R. Cooperberg, J. M. Broering, and P. R. Carroll, “Time trends and local variation in primary treatment of localized prostate cancer,” Journal of Clinical Oncology, vol. 28, no. 7, pp. 1117–1123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Chou, J. M. Croswell, T. Dana et al., “Screening for prostate cancer: a review of the evidence for the U.S. preventive services task force,” Annals of Internal Medicine, vol. 155, no. 11, pp. 762–771, 2011. View at Scopus
  9. V. Iremashvili, M. Manoharan, D. L. Rosenberg, and M. S. Soloway, “Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models,” British Journal of Urology, vol. 111, no. 4, pp. 574–579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. C. Large and S. E. Eggener, “Active surveillance for low-risk localized prostate cancer,” Oncology, vol. 23, no. 11, pp. 974–979, 2009. View at Scopus
  11. A. S. Duffield, T. K. Lee, H. Miyamoto, H. B. Carter, and J. I. Epstein, “Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails,” Journal of Urology, vol. 182, no. 5, pp. 2274–2279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Lees, M. Durve, and C. Parker, “Active surveillance in prostate cancer: patient selection and triggers for intervention,” Current Opinion in Urology, vol. 22, no. 3, pp. 210–215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. B. Barqawi, K. O. Rove, S. Gholizadeh, C. I. O'Donnell, H. Koul, and E. D. Crawford, “The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer,” Journal of Urology, vol. 186, no. 1, pp. 80–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. L. Dominguez-Escrig, S. R. C. McCracken, and D. Greene, “Beyond diagnosis: evolving prostate biopsy in the era of focal therapy,” Prostate Cancer, vol. 2011, Article ID 386207, 11 pages, 2011. View at Publisher · View at Google Scholar
  15. A. R. Patel and J. S. Jones, “Optimal biopsy strategies for the diagnosis and staging of prostate cancer,” Current Opinion in Urology, vol. 19, no. 3, pp. 232–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. Duffield, T. K. Lee, H. Miyamoto, H. B. Carter, and J. I. Epstein, “Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails,” Journal of Urology, vol. 182, no. 5, pp. 2274–2279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. R. J. Bott, M. P. A. Young, M. J. Kellett, and M. C. Parkinson, “Anterior prostate cancer: is it more difficult to diagnose?” British Journal of Urology, vol. 89, no. 9, pp. 886–889, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Haider, T. H. Van Der Kwast, J. Tanguay et al., “Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer,” American Journal of Roentgenology, vol. 189, no. 2, pp. 323–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Puech, N. Betrouni, N. Makni, A.-S. Dewalle, A. Villers, and L. Lemaitre, “Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results,” International Journal of Computer Assisted Radiology and Surgery, vol. 4, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. E. K. Vos, G. J. S. Litjens, T. Kobus, et al., “Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3T,” European Urology, vol. 64, no. 3, pp. 448–455, 2013.
  21. R. J. Hamilton and S. J. Freedland, “5-α reductase inhibitors and prostate cancer prevention: where do we turn now?” BMC Medicine, vol. 9, article 105, 2011. View at Publisher · View at Google Scholar · View at Scopus